Cardiovascular disease and cancer: Evidence for shared disease pathways and pharmacologic prevention

(2017) Cardiovascular disease and cancer: Evidence for shared disease pathways and pharmacologic prevention. Atherosclerosis. pp. 343-351. ISSN 0021-9150

Full text not available from this repository.

Abstract

Cardiovascular disease (CVD) and cancer are leading causes of mortality and morbidity worldwide. Strategies to improve their treatment and prevention are global priorities and major focus of World Health Organization's joint prevention programs. Emerging evidence suggests that modifiable risk factors including diet, sedentary lifestyle, obesity and tobacco use are central to the pathogenesis of both diseases and are reflected in common genetic, cellular, and signaling mechanisms. Understanding this important biological overlap is critical and may help identify novel therapeutic and preventative strategies for both disorders. In this review, we will discuss the shared genetic and molecular factors central to CVD and cancer and how the strategies commonly used for the prevention of atherosclerotic vascular disease can be applied to cancer prevention. (C) 2017 Elsevier B.V. All rights reserved.

Item Type: Article
Keywords: activated protein-kinase converting-enzyme-inhibitors coronary-artery-disease fatty-acid synthase randomized controlled-trials pioglitazone clinical-trial wnt/beta-catenin pathway type-2 diabetes-mellitus morbidly obese subjects smooth-muscle-cells
Divisions: Cardiovascular Research Institute > Isfahan Cardiovascular Research Center
Page Range: pp. 343-351
Journal or Publication Title: Atherosclerosis
Journal Index: ISI
Volume: 263
Identification Number: https://doi.org/10.1016/j.atherosclerosis.2017.06.001
ISSN: 0021-9150
Depositing User: مهندس مهدی شریفی
URI: http://eprints.mui.ac.ir/id/eprint/373

Actions (login required)

View Item View Item